Small molecules in targeted cancer therapy: advances, challenges, and future perspectives | Signal Transduction and Targeted Therapy
Changes in clinical trials of cancer drugs in mainland China over the decade 2009–18: a systematic review - The Lancet Oncology
Frontiers | Discovering Anti-Cancer Drugs via Computational Methods
The value of anticancer drugs — a regulatory view | Nature Reviews Clinical Oncology
Do patient access schemes for high-cost cancer drugs deliver value to society?—lessons from the NHS Cancer Drugs Fund - Annals of Oncology
Lessons Learned from Two Decades of Anticancer Drugs: Trends in Pharmacological Sciences
Emerging agents and regimens for cancer therapy
Innovation in Oncology Drug Development
By the Numbers: Cancer Drug Development - Clinical Oncology News
Overcoming cancer therapeutic bottleneck by drug repurposing | Signal Transduction and Targeted Therapy
Summary of cancer drugs in this review | Download Table
Overcoming cancer therapeutic bottleneck by drug repurposing | Signal Transduction and Targeted Therapy
Book - Frontiers in Clinical Drug Research - Anti-Cancer Agents | Bentham Science
Frontiers in Clinical Drug Research - Anti-Cancer Agents
Pharmacology-based ranking of anti-cancer drugs to guide clinical development of cancer immunotherapy combinations | Journal of Experimental & Clinical Cancer Research | Full Text
Pharmacology-based ranking of anti-cancer drugs to guide clinical development of cancer immunotherapy combinations | Journal of Experimental & Clinical Cancer Research | Full Text
FDA approves a new cancer drug targeted to genetic mutation, not cancer type
Service Unavailable ::: Clinical Cancer Drugs (Discontinued)
Risks and benefits of anticancer drugs in advanced cancer patients: A systematic review and meta-analysis - eClinicalMedicine
Cancer drugs tested in clinical trials or under U.S. FDA review by... | Download Scientific Diagram
The Ten Most Promising Cancer Drugs Being Trialled
Clinical development of targeted and immune based anti-cancer therapies | Journal of Experimental & Clinical Cancer Research | Full Text
Rationale for the design of an oncology trial using a generic targeted therapy multi‑drug regimen for NSCLC patients without treatment options (Review)
Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis - The Lancet Oncology
Clinical development of targeted and immune based anti-cancer therapies | Journal of Experimental & Clinical Cancer Research | Full Text
Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine - ScienceDirect
New research supports combining two clinical cancer drugs to treat specific colorectal cancers
How Are Cancer Drugs Discovered and Developed? | Cancer.Net
![PDF] Opportunities and challenges of implementing Pharmacogenomics in cancer drug development | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/29715e53ee783cfda555fb4efebeaad13ace3874/6-Figure3-1.png "PDF] Opportunities and challenges of implementing Pharmacogenomics in cancer drug development | Semantic Scholar")